Blackstone Inc
FOLD

Blackstone Inc’s Amicus Therapeutics FOLD Stock Holding History

Blackstone Inc’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-170,209
Closed -$2.46M – 577
2026
Q1 		$2.46M Sell
170,209
-2,403,995
-93% -$34.5M 0.01% 194
2025
Q4 		$36.7M Buy
2,574,204
+107,100
+4% +$1.05M 0.14% 61
2025
Q3 		$19.4M Hold
2,467,104
– – 0.08% 74
2025
Q2 		$14.1M Hold
2,467,104
– – 0.06% 77
2025
Q1 		$20.1M Hold
2,467,104
– – 0.08% 60
2024
Q4 		$23.2M Hold
2,467,104
– – 0.11% 58
2024
Q3 		$26.3M Hold
2,467,104
– – 0.11% 54
2024
Q2 		$24.5M Hold
2,467,104
– – 0.1% 57
2024
Q1 		$29.1M Hold
2,467,104
– – 0.12% 58
2023
Q4 		$35M Buy
+2,467,104
New +$28M 0.16% 50

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Blackstone Inc's FOLD Position: Q2 2026 in Review

Blackstone Inc sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 170,209 shares — an estimated $2.46M sold.

Blackstone Inc first reported a position in FOLD in Q4 2023 and held it in 10 quarters. The position peaked at $36.7M in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Blackstone Inc reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Blackstone Inc sold 170,209 Amicus Therapeutics shares in Q2 2026, an estimated $2.46M.
  • Blackstone Inc first reported a position in Amicus Therapeutics in Q4 2023 and held it in 10 quarters.
  • Blackstone Inc's Amicus Therapeutics position peaked at $36.7M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.